Nicotine Free
NDC 50845-0267, Abies Nigra, Aconitum Napellus, Avena Sativa, Caladium Seguinum, Ignatia Amara, Lobelia Inflata, Lung Suis, Nux Vomica, Plantago Major, Quebracho, Sticta Pulmonaria, Tabacum, spray, from Liddell Laboratories, Inc..
- Product NDC
- 50845-0267
- Status
- Listed
- Labeler
- Liddell Laboratories, Inc.
- Dosage form
- SPRAY
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50845-0267 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PICEA MARIANA RESIN10 [hp_X]/mL
- ACONITUM NAPELLUS WHOLE200 [hp_C]/mL
- AVENA SATIVA FLOWERING TOP1 [hp_X]/mL
- DIEFFENBACHIA SEGUINE WHOLE10 [hp_X]/mL
- STRYCHNOS IGNATII SEED200 [hp_C]/mL
- LOBELIA INFLATA WHOLE10 [hp_X]/mL
- SUS SCROFA LUNG6 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED10 [hp_X]/mL
- PLANTAGO MAJOR WHOLE3 [hp_X]/mL
- ASPIDOSPERMA QUEBRACHO-BLANCO BARK10 [hp_X]/mL
- LOBARIA PULMONARIA200 [hp_C]/mL
- TOBACCO LEAF200 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Plant Proteins [CS]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50845-0267-1 | 50845026701 | 30 mL in 1 BOTTLE, SPRAY (50845-0267-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 50845-0267 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50845-0267 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50845-0267. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.